CLASS II ONGOING Device recall · Reported 8 Mar 2023 · FDA Enforcement Report

Myla comprises Ast Filters in conjunction with Vitek MS recalled

Biomerieux is recalling Myla comprises Ast Filters in conjunction with Vitek MS, distributed nationwide in the US. The recall was initiated on 6 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesVersions 4.7 and 4.8
Quantity recalled19 systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1201-2023
FDA event ID
91617
Recalling firm
Biomerieux, Hazelwood, MO
Classification
Class II
Status
Ongoing
Recall initiated
6 Feb 2023
FDA classified
2 Mar 2023
Reported
8 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons
Device type
Medical Software

Timeline

6 Feb 2023Recall initiated by company
2 Mar 2023Classified by FDA+24 days
8 Mar 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

For users with MYLA V4.8.X / V4.9 that use VITEK MS to identify organisms as part of their workflow, AST filter rules that have been activated are not always being applied to AST results when sending the results to the clinician.

Product as listed by the FDA

MYLA comprises AST Filters in conjunction with VITEK MS; middleware which connects microbiology laboratory instruments for ID/AST and blood culture activities and the laboratory information system (LIS).

Where it was distributed

US Nationwide distribution to the states of Alabama, California, North Carolina, and Puerto Rico.

Nationwide AlabamaCaliforniaNorth CarolinaPuerto Rico

Questions about this recall

Is Myla comprises Ast Filters in conjunction with Vitek MS recalled?

Yes. Biomerieux recalled Myla comprises Ast Filters in conjunction with Vitek MS on 6 Feb 2023. The recall is Class II and its status is Ongoing. Recall number Z-1201-2023.

Why was it recalled?

For users with MYLA V4.8.X / V4.9 that use VITEK MS to identify organisms as part of their workflow, AST filter rules that have been activated are not always being applied to AST results when sending the results to the clinician.

Which lots are affected?

Versions 4.7 and 4.8

Where was it sold?

US Nationwide distribution to the states of Alabama, California, North Carolina, and Puerto Rico.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Biomerieux

All 476

Other Medical Software recalls

All 903